Filing Details
- Accession Number:
- 0001415889-24-025502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-22 16:20:04
- Reporting Period:
- 2024-10-18
- Accepted Time:
- 2024-10-22 16:20:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1817713 | Janux Therapeutics Inc. | JANX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1346824 | Ra Capital Management, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | No | No | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1619841 | M. Rajeev Shah | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1825376 | Ra Capital Nexus Fund Ii, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-18 | 1,200,000 | $44.75 | 9,317,246 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,048,406 | Indirect | See footnotes |
Footnotes
- Shares purchased in a private transaction pursuant to a stock purchase agreement dated September 12, 2024. The closing of the transaction was subject to certain customary conditions to closing, including the expiration or earlier termination of the applicable waiting periodunder the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. The closing conditions were satisfied, and the transaction closed, on October 18, 2024.
- RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- Held directly by the Fund.
- Held directly by the Nexus Fund II.